Earlier testing could help more people get the care they need before serious liver damage develops, including, for the first time, assessing everyone with type 2 diabetes.
Liver UK welcomes the publication of new national guidelines that mark a significant step forward in how liver disease is identified and investigated in the UK. The recommendations support our call for a major shift towards earlier detection, with more proactive testing for people at increased risk, including, for the first time, a recommendation to assess people with type 2 diabetes for advanced liver disease.
The recommendations set out a clear pathway for finding liver disease earlier, when treatment, support and lifestyle changes can prevent serious complications and, in many cases, halt or even reverse damage to the liver.
Published today, these British Society of Gastroenterology (BSG) guidelines were produced in association with the British Association for the Study of the Liver (BASL), the Royal College of GPs (RCGP) and Liver UK. They set out how healthcare professionals should investigate suspected liver disease in adults.
The guidelines cover abnormal liver blood tests, signs of possible liver disease on scans and targeted checks for people at higher risk. They update the 2018 guidance, with a broader focus on finding liver disease earlier, assessing its cause and severity, and deciding who needs specialist care.
Liver disease is often described as a silent condition because many people experience no symptoms until significant damage to the liver has already developed. As a result, many are diagnosed only when they have advanced liver disease, cirrhosis or liver cancer. The new recommendations aim to help identify people at risk before they reach this stage.
A major change for people with type 2 diabetes
For the first time, the guidelines recommend assessing people with type 2 diabetes for advanced liver disease, taking account of their age, other health conditions and overall fitness.
If you have type 2 diabetes, this means liver health should become a more routine part of your care. Assessment can help identify significant liver scarring even if you feel well.
The recommendations also cover people drinking harmful amounts of alcohol, people with abnormal liver blood tests and those whose scans suggest liver disease. The aim is to identify people at increased risk, rather than screen everyone.
Finding liver damage before you feel unwell
The guidelines recommend a two-step approach to checking for liver scarring, also called fibrosis. This starts with a FIB-4 score, calculated using blood test results and your age. Where needed, a further blood test or a liver stiffness scan can help decide whether you need more investigation or specialist care.
Finding liver disease early can give people the chance to prevent further damage and, in some cases, reverse it through treatment, support and lifestyle changes.
Why earlier diagnosis matters: Stephen and Michelle’s stories
Sara’s father, Stephen, lived with type 2 diabetes from 2000. Blood tests revealed abnormal liver results in 2014, but he was not referred for further assessment. In 2024, he was diagnosed with MASLD and cirrhosis. He died within four months, aged 62.
Sara said: “People living with type 2 diabetes should know that they can also be at risk of liver disease. My dad had abnormal liver tests, but his liver wasn’t monitored closely enough, and by the time he was diagnosed with MASLD and cirrhosis, it was too late. I hope these new guidelines mean that people with diabetes are identified earlier and given the monitoring and support they need.”
Michelle was diagnosed with cirrhosis on her 58th birthday. She had previously been diagnosed with type 2 diabetes, but says no one had spoken to her about her risk of liver disease. Routine diabetes blood tests in 2021 raised concerns about her liver enzymes. Further tests, including an ultrasound and FibroScan, revealed cirrhosis, despite her having no symptoms of liver damage.
Their experiences show why feeling well should not be a reason to overlook liver health.
Turning recommendations into everyday care
At Liver UK, we want early diagnosis to become routine, not the exception. That means clear pathways for GPs and other healthcare professionals, appropriate follow-up of abnormal liver blood tests and access to tests that assess liver scarring.
Vanessa Hebditch, our Director of Communications and Policy and a member of the guideline development group, said:
“In many cases, finding liver disease early gives people the opportunity to prevent progression and even reverse damage through treatment, support and lifestyle changes. That is why these recommendations have the potential to transform lives.”
We have developed a practical guide for GPs based on the recommendations, alongside information for the public about who should be tested, what tests to expect and when specialist referral may be needed.
FAQs
1. Why do we need these new guidelines now?
Liver disease is too often diagnosed when it is already advanced. In fact, three-quarters of people are diagnosed during an emergency hospital admission.
People can live with liver damage for years without knowing anything is wrong. We have an opportunity to change that.
These new guidelines give healthcare professionals a clearer, evidence-based approach to identifying people at risk and investigating liver disease earlier, when there is more opportunity to intervene, prevent further damage and improve outcomes.
2. Who is most at risk of liver disease, and who should be assessed?
There are several groups of people who are at increased risk of liver disease and who should be considered for assessment. This includes people with type 2 diabetes, obesity, those drinking harmful amounts of alcohol, people with abnormal liver blood tests and those with risk factors for viral hepatitis.
People with type 2 diabetes are at particularly high risk. Around two-thirds of people with type 2 diabetes in the UK also have metabolic dysfunction-associated steatotic liver disease (MASLD). With more than 4.1 million people diagnosed with type 2 diabetes in the UK, that means potentially around 2.7 million people are affected by both conditions.
The guidelines recommend that people with type 2 diabetes are assessed for advanced liver disease, taking account of their age, other health conditions and overall fitness.
The focus is on identifying and assessing people who are most at risk, rather than screening the entire population. Not everyone with fatty liver disease will develop advanced liver damage, but identifying those who are at greatest risk is really important.
3. Can liver disease be detected before symptoms develop, and can it be reversed?
Yes. Liver disease can develop silently, and people can have significant liver damage without experiencing any symptoms.
However, simple blood tests and non-invasive scans can help identify liver scarring before someone feels unwell.
If liver disease is identified early, action can often prevent further damage and, in some cases, reverse it. This may include addressing underlying causes such as obesity, type 2 diabetes or harmful alcohol use.
Even when liver damage is more advanced, early diagnosis means people can access the right treatment, support and monitoring to help manage their condition and reduce the risk of further complications.
4. What happens if tests show that someone has liver scarring?
It depends on how advanced the scarring is and what is causing it.
Some people can be managed in primary care, with support to address the underlying causes and reduce their risk of further liver damage. Others may need additional tests and referral to a liver specialist.
The guidelines recommend a two-step approach to assessing liver scarring. This usually starts with a FIB-4 score, calculated using routine blood test results and age. Depending on the result, a further blood test or a liver stiffness scan may be needed.
The important thing is that people are identified early enough to receive the right care, advice and support for their individual needs.
5. What do the guidelines mean for GPs and the NHS?
The guidelines provide an important opportunity to improve how liver disease is identified and managed across the NHS.
We need to move towards earlier identification and more proactive management of people at risk. That starts with recognising the warning signs, properly investigating abnormal liver blood tests and ensuring that appropriate fibrosis assessment follows, rather than simply repeating tests or overlooking abnormal results.
The guidelines are designed to support GPs and other primary care professionals to identify those most at risk and provide a clearer, more consistent approach to assessing patients and deciding what needs to happen next.
We appreciate there will be practical challenges, particularly around capacity, access to second-line tests and clear referral pathways. But identifying someone doesn’t automatically mean referring them to a specialist. It means they can receive appropriate advice and monitoring, while those at greatest risk can be identified and prioritised.
We also need to recognise that not diagnosing people early doesn’t make the problem go away. It simply means they may present later with much more advanced disease, when treatment options are more limited and outcomes are poorer.
Through our helpline, we regularly hear from people diagnosed only when they have developed cirrhosis or advanced liver disease, often after several missed opportunities for earlier intervention. Some are even facing liver transplantation as their only remaining treatment option.
Ultimately, identifying and managing liver disease earlier is better for patients and, in the longer term, makes sense for the NHS too.
6. What should I do if I’m worried about my liver health?
The first thing is not to wait for symptoms. Liver disease can develop silently, and people can have significant liver damage without feeling unwell.
If you have type 2 diabetes, drink alcohol at harmful levels, have abnormal liver blood tests or have other risk factors, speak to your GP and ask whether you should have your liver health assessed. You can also find out more about the tests used to detect liver disease, what they involve and what to expect in our guide: Getting tested for liver disease.
We’d also really encourage you to visit the Liver UK website and use our At-Risk Checker. It’s a simple, accessible tool that helps you understand whether you may be at increased risk of liver disease and whether you should take the next step and speak to your GP.
The important message is that you don’t have to wait until something feels wrong. Knowing your risk is the first step towards protecting your liver health.
7. What is Liver UK calling for, and what happens next?
We want to make early diagnosis routine, not the exception. We know who is most at risk of liver disease – people with obesity, type 2 diabetes and harmful alcohol use – and we know that effective pathways can identify those at risk, assess them for liver damage and ensure they receive the right care as early as possible.
But access to these pathways varies hugely across the UK. Our original research in 2021 found that only 26% of areas had comprehensive pathways for liver disease, while more than half had no pathway in place at all.
Our follow-up research in 2025 showed some progress, with comprehensive pathways increasing to 36%. But more than a third of areas still had no pathway, and the postcode lottery remains a real concern. In England, 80% of Integrated Care Board areas still lacked an effective pathway for the early detection and management of liver disease.
That’s why we’re calling for a clear, consistent roadmap for GPs and healthcare professionals across the UK. We want people at risk to be identified, offered appropriate fibrosis assessment, and those who need specialist care to be referred promptly. This needs to be supported by clear local pathways and access to the right tests.
Ultimately, we know what needs to be done. We now need the commitment and action to make it happen everywhere, so that early diagnosis becomes the norm, not the exception.


